B

Biogen

Develops therapies for neurological disorders

Executive Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeCambridge, MA, USAHybrid

About the Job

Requirements

  • An advanced degree is required: MD, PhD, PharmD, MS, or MBA.
  • 15 or more years of biopharmaceutical drug development experience, including significant leadership responsibility for clinical-stage development programs.
  • Direct experience serving as a Development Asset Lead, Program Team Leader, Global Program Head, Portfolio Leader, or equivalent enterprise-level development leader.
  • Demonstrated success leading the integrated development strategy for one or more clinical-stage assets through major development milestones.
  • Experience advancing programs through key value inflection points, including IND clearance, first-in-human studies, proof-of-concept generation, and major portfolio investment decisions.
  • Proven experience leading and developing senior scientific and development leaders within a matrixed organization.
  • Deep understanding of end-to-end drug development, including translational medicine, clinical development, regulatory strategy, safety, clinical pharmacology, and pharmaceutical sciences.
  • Strong understanding of Minimum Product Profile and Target Product Profile principles and their application to development strategy.
  • Demonstrated ability to evaluate and communicate portfolio value, development risk, probability of success, competitive differentiation, and resource trade-offs.
  • Proven track record presenting development strategies and recommendations to senior governance bodies and executive leadership teams.
  • Strong working knowledge of global regulatory requirements and drug development pathways across major health authorities.

Responsibilities

  • Lead, coach, and develop a team of Development Asset Leads, many operating at the Director and Senior Director level, while building organizational capability and succession strength within the function.
  • Mentor Development Asset Leads across early development clinical-stage and/or marketed assets in developing and executing integrated asset plans that balance scientific opportunity, probability of technical and regulatory success, competitive differentiation, timeline, cost, and portfolio value.
  • Guide teams through key development milestones, including IND-enabling activities, first-in-human studies, proof-of-concept generation, portfolio investment decisions, and lifecycle strategy planning.
  • Ensure effective cross-functional integration across Clinical Development, Clinical Operations, Regulatory Affairs, Safety, Biometrics, Clinical Pharmacology, Translational Medicine, CMC, Commercial, and other partner functions.
  • Support Development Asset Leads in driving accountability for functional deliverables and ensuring alignment between functional plans and overarching asset strategies.
  • Represent development programs and portfolio perspectives in discussions with senior leadership and governance forums, influencing critical investment and prioritization decisions.
  • Partner with Research, Development, Commercial, Finance, and Portfolio Strategy leaders to optimize resource allocation and portfolio performance.
  • Contribute to the evolution of Biogen's asset leadership model through departmental initiatives, communities of practice, and organizational capability-building efforts.

Desired Qualifications

  • Experience leading programs across multiple therapeutic areas and/or modalities.
  • Experience supporting NDA, BLA, MAA, or equivalent global regulatory submissions.
  • Experience participating in health authority interactions and regulatory strategy development.
  • Experience in both early-stage and late-stage development environments.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs